4//SEC Filing
HESTERBERG LYNDAL K. 4
Accession 0001493152-20-023601
CIK 0001642380other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 6:31 AM ET
Size
4.7 KB
Accession
0001493152-20-023601
Insider Transaction Report
Form 4
HESTERBERG LYNDAL K.
Sr VP, Research & Development
Transactions
- Award
Common Stock
2020-12-11+6,603→ 7,477 total
Footnotes (1)
- [F1]The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share.
Documents
Issuer
OncoCyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001689836
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 6:31 AM ET
- Size
- 4.7 KB